- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Debu Tripathy
A Step Forward in Treating KRAS G12-Mutated Lung Cancer
April 18, 2022
Article
Activating mutations in this class of oncogenes, specifically KRAS, have made a big step forward scientifically and clinically just in the last couple of years.
Some Immunity Is Better Than None Against COVID-19
March 20, 2022
Article
Many things can influence a patient’s response to the COVID-19 vaccine, such as their treatments or whether they have a higher tumor burden.
Examining Racial and Ethnic Disparities in Cancer Care
February 19, 2021
Article
The past year has spotlighted racial inequities not only in the U.S., but worldwide. It has also opened our eyes as to how a major health disruption — in this case, a pandemic — can aggravate the unacceptable status quo.
Metastatic Breast Cancer: The Future is Now
December 14, 2015
Article
In this issue of CURE magazine, we review the current approaches for the evaluation and treatment of metastatic breast cancer, and what the future holds.
A Worthwhile Investment
October 30, 2015
Article
Receiving a cancer diagnosis is a turning point, a moment at which patients need to start determining what seems like the right treatment path and exerting their best efforts to make it happen.
More Than a Buzzword, Immunotherapy Holds Great Promise
October 16, 2015
Article
Immunotherapy – it's the buzzword of the moment. It would be difficult to imagine an area of the field generating more excitement and hope than immuno-oncology is sparking right now.
Resolving a Controversy: The Value of PSA Screening
September 30, 2015
Article
Medical and scientific communities continue to weigh the value of PSA screening
A Cultural and Scientific Tug of War
August 26, 2015
Article
Throughout the history of medicine, there has been an intriguing interplay between pop culture and science.
Crossing the Divide
July 28, 2015
Article
Understanding how the immune system controls itself has led to advances in immunotherapy.
Debu Tripathy Discusses a Clinical Trial of Ibrance in Breast Cancer
June 11, 2015
Article
Debu Tripathy, editor-in-chief of CURE and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses adding the targeted drug Ibrance to the hormonal drug Faslodex.